首页> 外文期刊>Leukemia Research Reports >Acute myeloid leukemia with t(4;12)(q12;p13) treated with an allogeneic stem cell transplant: A case report and review of the literature
【24h】

Acute myeloid leukemia with t(4;12)(q12;p13) treated with an allogeneic stem cell transplant: A case report and review of the literature

机译:同种异体干细胞移植治疗t(4; 12)(q12; p13)的急性髓细胞白血病:一例病例报告并文献复习

获取原文
       

摘要

The t(4;12)(q12;p13) in acute myeloid leukemia (AML) is a rare finding with less than 30 cases described in the literature. The few cases reported show that this subtype of AML features dysplastic changes in all three cell lines, positivity for CD7, lymphoid appearing myeloblasts, basophilia, and low or absent myeloperoxidase activity [1,2]. Cases have been described in the literature as far back as 1989 [1], but prognosis remains poor with intensive chemotherapy alone. Here, we describe a case of an elderly patient with AML with t(4;12)(q12;p13) with extramedullary involvement who underwent an allogeneic stem cell transplant (alloSCT).
机译:急性髓细胞性白血病(AML)中的t(4; 12)(q12; p13)很少见,文献中报道的病例少于30例。报道的少数病例表明,这种亚型的AML在所有三种细胞系中均具有发育异常的改变,CD7阳性,淋巴样成肌细胞,嗜碱性粒细胞增多,髓过氧化物酶活性低或不存在[1,2]。早在1989年,文献中就已经描述了病例[1],但是仅进行强化化疗的预后仍然很差。在这里,我们描述了一位患有髓外侵犯的t(4; 12)(q12; p13)的老年AML患者,该患者接受了同种异体干细胞移植(alloSCT)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号